Skip to content

DENTSPLY SIRONA XRAY Cash & Equivalents

Cash & Equivalents at other companies

Align Technology logo
Align TechnologyALGN
$1.06B+21.4%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$1.08B+0.5%
Solventum logo
SolventumSOLV
$561M+5.1%
Henry Schein logo
Henry ScheinHSIC
$138M+8.7%
Globus Medical logo
Globus MedicalGMED
$560.95M+21.6%
Stryker logo
StrykerSYK
$2.88B+24.1%

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%
Free cash flow-$12.0M0.0%

Valuation

See full
Market cap$2.04B-22.1%
Enterprise value$4.18B-10.8%
P/S0.6×-0.2×

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Return on equity-37.7%+4.0pp
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's cash & equivalents?
DENTSPLY SIRONA (XRAY) reported cash & equivalents of $190M in Q1 2026.
How has DENTSPLY SIRONA's cash & equivalents changed year-over-year?
DENTSPLY SIRONA's cash & equivalents decreased by 52.3% year-over-year, from $398M to $190M.
What is the long-term trend for DENTSPLY SIRONA's cash & equivalents?
Over 5 years (2020 to 2025), DENTSPLY SIRONA's cash & equivalents has grown at a -5.7% compound annual growth rate (CAGR), from $438M to $326M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.